Biochemical Detection of cGMP From Past to Present: An Overview.
Cyclic guanosine monophosphate (cGMP), generated via the guanylate cyclase (GC)-catalyzed conversion from GTP, is unequivocally recognized as crucial second messenger, intimately involved in the regulation of a broad range of physiological processes such as long term potentiation, blood pressure regulation, or platelet aggregation (for review: Hobbs 2000). Since its first identification in rat urine by Ashman and co-workers (1963), various approaches have been conceived and established to quantify cGMP in biological samples, or to detect cGMP as the reaction product of enzymatic assays, allowing the determination of kinetic parameters. These approaches have evolved from laborious handling of small numbers of samples with average sensitivity to highly developed biochemical detection assays allowing the processing of very large numbers of samples. The present article focuses upon the history of biochemical cGMP detection from the pioneering work of the early years to the actual state-of-the-art approaches for the detection of this important biological messenger.
Schmidt
Peter M
PM
CSIRO Molecular & Health Technologies, 343 Royal Parade, Parkville, VIC, 3052, Australia. peter.schmidt@csiro.au
D000818:Animals; D001681:Biological Assay / Q000266:history / Q000379:methods* / Q000639:trends; D006152:Cyclic GMP / Q000032:analysis*; D006162:Guanylate Cyclase / Q000378:metabolism*; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans
D006162:Guanylate Cyclase; D006152:Cyclic GMP